$AVNC MiddleBrook Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in MiddleBrook Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MiddleBrook Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in MiddleBrook Pharmaceuticals, Inc. for free.
CIK Number: 0001161924
IRS Number: 522208264
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AVNC
Company Address: 20425 SENECA MEADOWS PARKWAY GERMANTOWN 20878
Former name: ADVANCIS PHARMACEUTICAL CORP, date of change: 2001-11-06
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
MiddleBrook Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 07 2010 | AVNC | MiddleBrook Pharma ... | Cole Brad | SVP, GC | Sell | S | 0.08 | 19,900 | 1,562 | 100 | 20 K to 100 (-99.50 %) |
Nov 22 2010 | AVNC | MiddleBrook Pharma ... | EGI-MBRK, L.L.C. | 10% Owner | Buy | J | 0.00 | 19,022,726 | 0 | 19,022,726 | 0 to 19 M |
Nov 22 2010 | AVNC | MiddleBrook Pharma ... | EGI-MBRK, L.L.C. | 10% Owner | Sell | J | 0.00 | 32,303,030 | 0 | 0 | 32.3 M to 0 (-100.00 %) |
Dec 21 2009 | AVNC | MiddleBrook Pharma ... | EGI-MBRK, L.L.C. | 10% Owner | Buy | P | 0.42 | 2,000,000 | 830,000 | 32,303,030 | 30.3 M to 32.3 M (+6.60 %) |
Nov 25 2009 | AVNC | MiddleBrook Pharma ... | BLYTH LORD JAMES | Director | Option Exercise | A | 0.70 | 500,000 | 350,000 | 500,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | PATE WILLIAM | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | VOGELBAUM MARTIN | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | Sotir Mark R | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | BLYTH LORD JAMES | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | DUGAN RICHARD W | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | DOUGLAS R GORDON | Director | Option Exercise | A | 1.53 | 30,000 | 45,900 | 30,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | WERNER HAROLD R | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Jun 24 2009 | AVNC | MiddleBrook Pharma ... | CAVANAUGH JAMES H | Director | Option Exercise | A | 1.53 | 20,000 | 30,600 | 20,000 | |
Mar 12 2009 | AVNC | MiddleBrook Pharma ... | Miller Timothy L | SVP, Sales Ops & Ad ... | Grant | A | 1.43 | 22,500 | 32,175 | 22,500 | 0 to 22.5 K |
Dec 02 2008 | AVNC | MiddleBrook Pharma ... | Koos Frank | SVP, Sales & Busine ... | Option Exercise | A | 1.31 | 325,000 | 425,750 | 325,000 |
View all MiddleBrook Pharmaceuticals, Inc. insider transactions.